GlassScriptPhysician profile
Michael C Francis
NPI 1912959586
$338.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $96.39 · 2021: $52.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.09 | 2019-2020 | |
| Pfizer INC. | $72.11 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $41.64 | 2019-2020 | |
| Abbott Laboratories | $24.53 | 2019 | |
| Zyla Life Sciences, INC. | $16.93 | 2019 | |
| Medtronic USA, INC. | $16.11 | 2019 | |
| Amgen INC. | $16.10 | 2020 | |
| Lilly USA, LLC | $12.71 | 2019 | |
| Pacira Therapeutics, INC. | $12.48 | 2019 | |
| Horizon Therapeutics Plc | $11.41 | 2019 | |
| Electronic Waveform Lab, INC. | $10.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.